BRPI0413430A - derivados de amida - Google Patents

derivados de amida

Info

Publication number
BRPI0413430A
BRPI0413430A BRPI0413430-3A BRPI0413430A BRPI0413430A BR PI0413430 A BRPI0413430 A BR PI0413430A BR PI0413430 A BRPI0413430 A BR PI0413430A BR PI0413430 A BRPI0413430 A BR PI0413430A
Authority
BR
Brazil
Prior art keywords
infection
caused
chickenpox
medicines
zoster virus
Prior art date
Application number
BRPI0413430-3A
Other languages
English (en)
Inventor
Toru Kontani
Junji Miyata
Wataru Hamaguchi
Tomoaki Kawano
Akio Kamikawa
Hiroshi Suzuki
Kenji Sudo
Original Assignee
Astellas Pharma Inc
Rational Drug Design Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc, Rational Drug Design Lab filed Critical Astellas Pharma Inc
Publication of BRPI0413430A publication Critical patent/BRPI0413430A/pt
Publication of BRPI0413430B1 publication Critical patent/BRPI0413430B1/pt
Publication of BRPI0413430B8 publication Critical patent/BRPI0413430B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

"DERIVADOS DE AMIDA". O objetivo consiste em se propor um composto inédito útil em medicamentos, especialmente em medicamentos para diversas doenças causadas por infecção com vírus que pretendem à família Herpesviridae, isto é, na prevenção ou tratamento de infecções com diversos herpesvírus, mais especificamente, varicela causada pela infecção com vírus zoster de varicela, herpes zoster causado por infecção repetida com vírus zoster de varicela persistente, herpes labial, e encefalite herpética causada por infecção com HSV1, herpes genital causado por infecção com HSV-2 etc. Um derivado de N-{2-¢(4-fenil substituído)amino!-2-oxoetil} tetraidro-2H-tiopiran-4-carboxamida tendo um substituinte heteroarila específico de 5 ou 6 membros na posição 4 tem uma atividade antiviral favorável e torna possível o tratamento das doenças acima por administração oral de uma pequena dose.
BRPI0413430A 2003-08-08 2004-08-05 derivados de amida os um sal destes, composição farmacêutica compreendendo os mesmos e uso destes para o tratamento de doenças em que está implicado o herpesvírus. BRPI0413430B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003290850 2003-08-08
JP2003-290850 2003-08-08
PCT/JP2004/011573 WO2005014559A1 (ja) 2003-08-08 2004-08-05 アミド誘導体

Publications (3)

Publication Number Publication Date
BRPI0413430A true BRPI0413430A (pt) 2006-10-17
BRPI0413430B1 BRPI0413430B1 (pt) 2019-04-30
BRPI0413430B8 BRPI0413430B8 (pt) 2021-05-25

Family

ID=34114142

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0413430A BRPI0413430B8 (pt) 2003-08-08 2004-08-05 derivados de amida os um sal destes, composição farmacêutica compreendendo os mesmos e uso destes para o tratamento de doenças em que está implicado o herpesvírus.

Country Status (19)

Country Link
US (2) US7465748B2 (pt)
EP (1) EP1652843B1 (pt)
JP (1) JP4549974B2 (pt)
KR (1) KR101157074B1 (pt)
CN (1) CN100445271C (pt)
AU (1) AU2004263448B2 (pt)
BR (1) BRPI0413430B8 (pt)
CA (1) CA2535199C (pt)
CY (1) CY1115461T1 (pt)
DK (1) DK1652843T3 (pt)
ES (1) ES2462292T3 (pt)
MX (1) MXPA06001526A (pt)
NO (1) NO335467B1 (pt)
PL (1) PL1652843T3 (pt)
PT (1) PT1652843E (pt)
RU (1) RU2336273C2 (pt)
SI (1) SI1652843T1 (pt)
TW (1) TW200505894A (pt)
WO (1) WO2005014559A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2004747A3 (cs) * 2001-12-21 2004-11-10 Novo Nordisk A/S Deriváty amidů jako GK aktivátory
JP4881559B2 (ja) * 2002-06-27 2012-02-22 ノボ・ノルデイスク・エー／エス 治療薬としてのアリールカルボニル誘導体
TW200505894A (en) * 2003-08-08 2005-02-16 Yamanouchi Pharma Co Ltd Tetrahydro-2H-thiopyran-4-carboxamide derivative
DK1723128T3 (da) * 2004-01-06 2013-02-18 Novo Nordisk As Heteroarylurinstoffer og deres anvendelse som glucokinaseaktivatorer
WO2006082822A1 (ja) * 2005-02-02 2006-08-10 Astellas Pharma Inc. アシクロビル耐性ヘルペスウイルスによる疾患の予防・治療剤
WO2006082820A1 (ja) * 2005-02-02 2006-08-10 Astellas Pharma Inc. 性器ヘルペス治療剤
WO2006082821A1 (ja) * 2005-02-02 2006-08-10 Astellas Pharma Inc. ヘルペスウイルスが関与する疾患の予防若しくは治療剤
JP5011739B2 (ja) * 2005-02-03 2012-08-29 アステラス製薬株式会社 テトラヒドロ−２ｈ−チオピラン−４−カルボキサミド誘導体を含有する医薬組成物
CA2614518A1 (en) * 2005-07-08 2007-01-18 Novo-Nordisk A/S Dicycloalkyl urea glucokinase activators
ES2382815T3 (es) * 2005-07-08 2012-06-13 Novo Nordisk A/S Dicicloalquilcarbamoil ureas como activadores de glucoquinasa
CA2615938C (en) 2005-07-14 2014-04-29 Novo-Nordisk A/S Urea glucokinase activators
WO2008084043A1 (en) * 2007-01-09 2008-07-17 Novo Nordisk A/S Urea glucokinase activators
EP2099777B1 (en) * 2007-01-11 2015-08-12 Novo Nordisk A/S Urea glucokinase activators
DE102008014523A1 (de) * 2008-03-15 2009-09-17 Robert Bosch Gmbh Heizgerät
EP2263671B1 (en) * 2008-04-02 2016-07-20 Astellas Pharma Inc. Amide derivative-containing pharmaceutical composition
EP2565191B1 (en) * 2008-05-14 2014-10-08 Astellas Pharma Inc. 4-(Indol-7-ylcarbonylaminomethyl)cyclohexanecarboxylic acid derivatives as EP4 receptor antagonists useful for the treatment of chronic renal failure or diabetic nephropathy
US20110201659A1 (en) * 2008-10-20 2011-08-18 Astellas Pharma Inc. Agent for preventing or treating zoster-associated pain
CN108623577B (zh) * 2018-05-08 2020-09-25 山东百诺医药股份有限公司 阿莫奈韦及其中间体的制备方法
WO2019241089A1 (en) 2018-06-12 2019-12-19 Vtv Therapeutics Llc Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
WO2020038812A1 (en) * 2018-08-20 2020-02-27 Rijksuniversiteit Groningen New process for the preparation of amenamevir
TW202038947A (zh) 2018-11-28 2020-11-01 德商創新分子有限責任公司 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0871619B1 (en) * 1995-12-29 2002-11-06 Boehringer Ingelheim Pharmaceuticals Inc. Phenyl thiazole derivatives with anti herpes virus properties
US6288091B1 (en) * 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
AU3289299A (en) * 1998-02-19 1999-09-06 Tularik Inc. Antiviral agents
WO2000029399A1 (en) * 1998-11-12 2000-05-25 Boehringer Ingelheim (Canada) Ltd. Antiherpes compounds
JP2002539119A (ja) * 1999-03-08 2002-11-19 バイエル アクチェンゲゼルシャフト チアゾリルウレア誘導体および抗ウイルス剤としてのそれらの使用
WO2000071507A2 (en) * 1999-05-24 2000-11-30 Cor Therapeutics, Inc. INHIBITORS OF FACTOR Xa
AU5723500A (en) * 1999-05-24 2000-12-12 Cor Therapeutics, Inc. Inhibitors of factor xa
CA2428184C (en) * 2000-11-10 2010-03-30 Yamanouchi Pharmaceutical Co., Ltd. Thiazolylphenylcarbamoylmethyl amide derivative
DE10139060A1 (de) 2001-08-08 2003-02-20 Merck Patent Gmbh Phenylderivate
WO2003095435A1 (fr) 2002-05-09 2003-11-20 Yamanouchi Pharmaceutical Co., Ltd. Derives d'amides
TW200505894A (en) * 2003-08-08 2005-02-16 Yamanouchi Pharma Co Ltd Tetrahydro-2H-thiopyran-4-carboxamide derivative

Also Published As

Publication number Publication date
CY1115461T1 (el) 2017-01-04
US20050032855A1 (en) 2005-02-10
KR20060073928A (ko) 2006-06-29
RU2336273C2 (ru) 2008-10-20
DK1652843T3 (da) 2014-05-05
AU2004263448B2 (en) 2009-02-05
WO2005014559A1 (ja) 2005-02-17
EP1652843B1 (en) 2014-04-02
US7465748B2 (en) 2008-12-16
PT1652843E (pt) 2014-06-02
JPWO2005014559A1 (ja) 2006-10-05
AU2004263448A1 (en) 2005-02-17
CA2535199C (en) 2010-12-14
CA2535199A1 (en) 2005-02-17
EP1652843A1 (en) 2006-05-03
NO335467B1 (no) 2014-12-15
EP1652843A4 (en) 2010-07-28
SI1652843T1 (sl) 2014-06-30
ES2462292T3 (es) 2014-05-22
CN1832930A (zh) 2006-09-13
MXPA06001526A (es) 2006-05-25
JP4549974B2 (ja) 2010-09-22
TW200505894A (en) 2005-02-16
KR101157074B1 (ko) 2012-06-22
BRPI0413430B1 (pt) 2019-04-30
RU2006106922A (ru) 2006-08-27
CN100445271C (zh) 2008-12-24
TWI341311B (pt) 2011-05-01
US6903125B2 (en) 2005-06-07
NO20061100L (no) 2006-03-07
BRPI0413430B8 (pt) 2021-05-25
US20060229295A1 (en) 2006-10-12
PL1652843T3 (pl) 2014-09-30

Similar Documents

Publication Publication Date Title
BRPI0413430A (pt) derivados de amida
WO1998056761A3 (en) Benzimidazole derivatives
BR0316407A (pt) Derivados de nucleosìdeo antiviral
ES2160046A1 (es) Derivados pentapeptidicos.
JPS59130223A (ja) 相乗作用を示す抗ヘルペス組成物
Bacon et al. An overview of the further evaluation of penciclovir against herpes simplex virus and varicella-zoster virus in cell culture highlighting contrasts with acyclovir
DE60112790D1 (de) Amidderivate
AU653248B2 (en) Topical composition enhancing healing of herpes lesions
Collins et al. Comparison of activity of herpes virus inhibitors
Maudgal et al. Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.
JPS60202822A (ja) 抗ウイルス薬
Pancheva Potentiating effect of ribavirin on the anti-herpes activity of acyclovir
ES2105923A1 (es) Composiciones para el tratamiento de una infeccion y una enfermedad causadas por el virus de la hepatitis b (hbv).
DE69906625D1 (de) Arabinosyladenin-Derivative
Hayashi et al. In vitro and in vivo evaluation of a novel antiherpetic flavonoid, 4′-phenylflavone, and its synergistic actions with acyclovir
DK2374461T3 (en) Piroxicam for the prophylactic and therapeutic treatment of herpes infections
DE69510582T2 (de) Purinderivate und ihre pharmazeutisch akzeptablen Salze
Connell et al. Synergistic activity of combinations of recombinant human alpha interferon and acyclovir, administered concomitantly and in sequence, against a lethal herpes simplex virus type 1 infection in mice
Mastikova et al. Antiviral activity of dipyridamole in experimental viral infections in mice
EP0101441A4 (en) ANTI-VIRAL COMPOSITIONS.
EP1844776A4 (en) AGENT FOR THE PREVENTION / TREATMENT OF A DISEASE CAUSED BY A HERPES ACYCLOVIR-RESISTANT VIRUS
CA2150671C (en) Compositions containing acyclovir-like compounds and 2'-vinyl substituted nucleoside analogs for the treatment of viral infections
Centifanto et al. 9-(2-hydroxyethoxymethyl) guanine as an inhibitor of herpes simplex virus replication.
Pallasch et al. Acyclovir and herpesvirus infections: a review of the literature
Rachlis Antiviral therapy

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25G Requested change of headquarter approved

Owner name: ASTELLAS PHARMA INC. (JP) , RATIONAL DRUG DESIGN L

B25A Requested transfer of rights approved

Owner name: ASTELLAS PHARMA INC. (JP)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/04/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/04/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/08/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF